- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07516197
From Global Balance Metrics to Plane-Specific Signatures: Identifying Postural Instability Phenotypes in Females (APSI-MLSI)
April 7, 2026 updated by: Azza Mohammed, Cairo University
The main aim of this study was to evaluate anterior-posterior (AP) and medial-lateral (ML) stability, examine proportional stability, and explore associations with BMI in healthy young adult females.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Postural stability is essential for functional performance and injury prevention, with directional control influenced by neuromuscular and anthropometric factors.
Limited data exist on proportional stability patterns and their relationship with body mass index (BMI).
Therefore, the main aim of this study was to evaluate anterior-posterior (AP) and medial-lateral (ML) stability, examine proportional stability, and explore associations with BMI in healthy young adult females.
Study Type
Observational
Enrollment (Actual)
111
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Giza Governorate
-
Dokki, Giza Governorate, Egypt, 11432
- Faculty of Physical Therapy, Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
A total of 111 healthy female participants were recruited for this study, representing a homogeneous sample of young adults, aged 20-29 years, reflecting a population within early adulthood, a stage typically characterized by optimal neuromuscular function and postural control capacity.
Description
Inclusion Criteria:
- a relatively uniform and non-clinical population
Exclusion Criteria:
- any history of neurological disorders, vestibular dysfunction, musculoskeletal injuries affecting the lower limbs or spine within the preceding six months
- or any condition known to impair balance. Individuals with visual impairments not corrected by lenses
- taking medications that could influence neuromuscular performance or postural control
- those engaged in specialized balance training or high-level athletic activities were also excluded to minimize potential confounding effects.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
APSI
Time Frame: one month
|
anterior-posterior stability index
|
one month
|
|
MLSI
Time Frame: one month
|
Mediolateral stability index
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI
Time Frame: one months
|
body mass index
|
one months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Azza M Abdelmohsen, professor, Cairo University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zhang X, Ruan B, Gao Q. Dynamic postural stability indices in athletes: a case-control study on chronic ankle instability during multi-directional landing assessments. BMC Musculoskeletal Disorders. 2025 Dec;26(1):1093.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2024
Primary Completion (Actual)
September 25, 2024
Study Completion (Actual)
October 25, 2024
Study Registration Dates
First Submitted
March 27, 2026
First Submitted That Met QC Criteria
April 2, 2026
First Posted (Actual)
April 7, 2026
Study Record Updates
Last Update Posted (Actual)
April 8, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- approved from IRB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.